Cue Biopharma, Inc. (CUE)

19.95 +0.53 (+2.73%) USD  |  NASDAQ  |  Nov 03, 13:31
More

Cue Biopharma EPS Diluted (5 Year Growth)

EPS Diluted (5 Year Growth) Chart

View EPS Diluted (5 Year Growth) for CUE.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00

Historical EPS Diluted (5 Year Growth) Data

View and export this data back to 2020. Start Trial.
Date Value
December 31, 2025 --
December 31, 2024 --
December 31, 2023 --
Date Value
December 31, 2022 --
December 31, 2021 --
December 31, 2020 --

EPS Diluted (5 Year Growth) Range, Past 5 Years

View EPS Diluted (5 Year Growth) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

EPS Diluted (5 Year Growth) Benchmarks

View EPS Diluted (5 Year Growth) Benchmarks
Start Trial
Cypherpunk Technologies, Inc. Upgrade
Yarrow Bioscience, Inc. Upgrade
Faeth Therapeutics, Inc. Upgrade
Indaptus Therapeutics, Inc. Upgrade
Pyxis Oncology, Inc. Upgrade